Patent details

EP2379532 Title: COMPOUNDS USEFUL FOR INHIBITING CHK1

Basic Information

Publication number:
EP2379532
PCT Application Number:
PCT/US/2009/067437
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP097685861
PCT Publication Number:
WO/2010/077758
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOUNDS USEFUL FOR INHIBITING CHK1
French Title of Invention:
COMPOSÉS UTILES POUR INHIBER CHK1
German Title of Invention:
ZUM INHIBIEREN VON CHK1 GEEIGNETE VERBINDUNGEN
SPC Number:

Dates

Filing date:
10/12/2009
Grant date:
20/02/2013
EP Publication Date:
20/02/2013
PCT Publication Date:
08/07/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/10/2011
EP B1 Publication Date:
20/02/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
10/12/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/12/2009
 
 

Name:
Eli Lilly and Company
Address:
Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
27/02/2013
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
KASAR Ramesh
Address:
United States (US)

2

Name:
MYERS Steven, Scott
Address:
United States (US)

3

Name:
HOLCOMB Ryan, Coatsworth
Address:
United States (US)

4

Name:
FAROUZ Francine, S.
Address:
United States (US)

Priority

Priority Number:
138176 P
Priority Date:
17/12/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 403/12;

Annual Fees

Annual Fee Due Date:
31/12/2026
Annual Fee Number:
18
Annual Fee Amount:
262 Euro
Expected Payer:
Last Annual Fee Payment Date:
29/12/2025
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages